Cucurbitacin
Standard
Cucurbitacin : ancient compound shedding new light on cancer treatment. / Lee, Dhong Hyun; Iwanski, Gabriela B; Thoennissen, Nils H.
in: SCI WORLD J, Jahrgang 10, 2010, S. 413-8.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Cucurbitacin
T2 - ancient compound shedding new light on cancer treatment
AU - Lee, Dhong Hyun
AU - Iwanski, Gabriela B
AU - Thoennissen, Nils H
PY - 2010
Y1 - 2010
N2 - Cucurbitacins and their derivatives are triterpenoids found in medicinal plants known for their diverse pharmacological and biological activities, including anticancer effects, throughout human history. Although initial attention to cucurbitacin as a potential anticancer drug withered for decades, recent discoveries showing that cucurbitacin is a strong STAT3 (Signal Transducers and Activators of Transcription-3) inhibitor have reclaimed the attention of the drug industry one more time. There is increasing evidence showing that some cucurbitacins not only inhibit the JAK-STAT pathway, but also affect other signaling pathways, such as the MAPK pathway, which are also known to be important for cancer cell proliferation and survival. Moreover, some reports have shown the synergistic effect of cucurbitacins with known chemotherapeutic agents, such as doxorubicin and gemcitabine. In this review, we will summarize the recent discoveries regarding molecular mechanisms of action of cucurbitacins in human cancer cells and discuss the possibilities of cucurbitacin as a future anticancer drug in clinical settings.
AB - Cucurbitacins and their derivatives are triterpenoids found in medicinal plants known for their diverse pharmacological and biological activities, including anticancer effects, throughout human history. Although initial attention to cucurbitacin as a potential anticancer drug withered for decades, recent discoveries showing that cucurbitacin is a strong STAT3 (Signal Transducers and Activators of Transcription-3) inhibitor have reclaimed the attention of the drug industry one more time. There is increasing evidence showing that some cucurbitacins not only inhibit the JAK-STAT pathway, but also affect other signaling pathways, such as the MAPK pathway, which are also known to be important for cancer cell proliferation and survival. Moreover, some reports have shown the synergistic effect of cucurbitacins with known chemotherapeutic agents, such as doxorubicin and gemcitabine. In this review, we will summarize the recent discoveries regarding molecular mechanisms of action of cucurbitacins in human cancer cells and discuss the possibilities of cucurbitacin as a future anticancer drug in clinical settings.
KW - Antineoplastic Agents
KW - Cucurbitacins
KW - Drug Screening Assays, Antitumor
KW - Humans
KW - MAP Kinase Signaling System
KW - Neoplasms
KW - Transcription Factors
U2 - 10.1100/tsw.2010.44
DO - 10.1100/tsw.2010.44
M3 - SCORING: Journal article
C2 - 20209387
VL - 10
SP - 413
EP - 418
JO - SCI WORLD J
JF - SCI WORLD J
SN - 1537-744X
ER -